People · Operator
Named in public records as an officer, director or promoter · active 2013–2014 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| EmboMedics, Inc. | — | Biotechnology | Series A | $5.9M | $26.8M | 2013 |
Omid Souresrafil at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Omid Souresrafil on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Robert Cohen | 1 | 11 |
| Jon Freeman | 1 | 5 |
| Reza Malek | 1 | 3 |
| Gerald D. Van Eeckhout | 1 | 2 |
| Jafar Golzarian | 1 | 1 |
| Robert D. Halverson | 1 | 1 |
| Robert Halverson | 1 | 1 |
| Kraig D. Black | 1 | 1 |
| Lihui Weng | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.